SARS-CoV-2: a storm is raging

Cited by (1,000)

Items 101–200 of 1,000

1. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody
   Simon Gebremeskel, Julia Schanin, Krysta Mila Coyle, Melina Butuci, Thuy T. Luu, Emily C. Brock, Alan Xu, Alan Wong, John Leung, Wouter Korver et al. · 2021 · Frontiers in Immunology
2. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients
   Marton L. Olbei, Isabelle Hautefort, Dezső Módos, Agatha Treveil, Martina Poletti, Lejla Gul, Claire D Shannon-Lowe, Tamas Douglas Korcsmaros · 2021 · Frontiers in Immunology
3. The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals
   Carlos A. Cañas · 2020 · Medical Hypotheses
4. Immunomodulatory activity of β-glucan polysaccharides isolated from different species of mushroom – A potential treatment for inflammatory lung conditions
   Emma J. Murphy, Emanuele Rezoagli, Robert Edward Pogue, Bianca Simonassi-Paiva, Ismin Zainol Abidin, Gustavo Waltzer Fehrenbach, Emer O'Neil, Ian Major, John Gerard Laffey, Neil J. Rowan · 2021 · The Science of The Total Environment
5. The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19
   Ali Attiq, Lui Jin Yao, Sheryar Afzal, Mansoor Ali Khan · 2021 · International Immunopharmacology
6. Immunoregulation with mTOR inhibitors to prevent COVID‐19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines
   Yunfeng Zheng, Renfeng Li, Shunai Liu · 2020 · Journal of Medical Virology
7. Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome
   Wenchun Qu, Zhen Wang, Joshua M. Hare, Guojun Bu, Jorge M. Mallea, Jorge M. Pascual, Arnold I. Caplan, Joanne Kurtzberg, Abba Chedi Zubair, Eva Kubrova et al. · 2020 · Stem Cells Translational Medicine
8. Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes
   Mina Thabet Kelleni · 2020 · Biomedicine & Pharmacotherapy
9. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach
   Gerwyn Morris, Chiara C. Bortolasci, Basant K. Puri, LISA S. OLIVE, Wolfgang Marx, Adrienne E O'Neil, Eugene Athan, Andre Ferrer Carvalho, Michael H. J. Maes, Ken R. Walder et al. · 2020 · Life Sciences
10. Application of a data-driven XGBoost model for the prediction of COVID-19 in the USA: a time-series study
    Zheng-gang Fang, Shuqin Yang, Cai-Xia Lv, Shu-Yi An, Wei Wu · 2022 · BMJ Open
11. Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets
    Krishna Sriram, Paul A. Insel · 2020 · Physiological Reviews
12. The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective
    Shamshul Ansari, John Philip Hays, Andrew Haddon Kemp, Raymond C. Okechukwu, Jayaseelan Murugaiyan, Mutshiene Deogratias Ekwanzala, Maria Josefina Ruiz Alvarez, Maneesh Paul Satyaseela, Chidozie Declan Iwu, Clara Ballesté‐Delpierre et al. · 2021 · JAC-Antimicrobial Resistance
13. Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2’-O-Methylation of Viral RNA
    José Antonio Encinar, Javier Abel Menéndez · 2020 · Viruses
14. An analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination
    Han-Qi Zhang, Buzi Cao, Qingtai Cao, Marady Hun, Lin Cao, Mingyi Zhao · 2023 · Human Vaccines & Immunotherapeutics
15. Biomarkers of post-covid depression
    Lorkiewicz, Piotr, Waszkiewicz, Napoleon · 2021 · Journal of Clinical Medicine
16. The intriguing features of COVID-19 in children and its impact on the pandemic
    Marco Aurélio Palazzi Sáfadi · 2020 · Jornal de Pediatria
17. Temporal profiling of cytokines in passively expressed sweat for detection of infection using wearable device
    Badrinath Jagannath, Kai‐Chun Lin, Madhavi L Pali, Devangsingh Sankhala, Sriram Muthukumar, Shalini Prasad · 2021 · Bioengineering & Translational Medicine
18. Hepatic consequences of COVID-19 infection. Lapping or biting?
    Piero Portincasa, Marcin Jan Krawczyk, Antonia Machill, Frank Lammert, Agostino Di Ciaula · 2020 · European Journal of Internal Medicine
19. Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia
    Enrrico Bloise, Jianhong Zhang, Jittanan Nakpu, Hirotaka Hamada, Caroline Dunk, Siliang Li, Güínever E. Império, Lubna Nadeem, Mark Kibschull, Phetcharawan Lye et al. · 2020 · American Journal of Obstetrics and Gynecology
20. The cytokine storm of COVID-19: a spotlight on prevention and protection
    Lucie Pearce, Sean M. Davidson, Derek M. Yellon · 2020 · Expert Opinion on Therapeutic Targets
21. Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination
    Crystal Y. Zheng, Indrani Kar, Claire Kaori Chen, Crystal Sau, Sophia Woodson, Alessandro Serra, Hesham Abboud · 2020 · CNS Drugs
22. Vascular Manifestations of COVID-19 – Thromboembolism and Microvascular Dysfunction
    Kirsty A. Roberts, Liam Sean Colley, Thomas A. Agbaedeng, Georgina M. Ellison, Mark Ross · 2020 · Frontiers in Cardiovascular Medicine
23. Made to order: emergency myelopoiesis and demand-adapted innate immune cell production
    James W. Swann, Oakley C. Olson, Emmanuelle A. Passegue · 2024 · Nature reviews. Immunology
24. Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19
    Mario Alejandro Bautista-Vargas, Fabio Bonilla‐Abadía, Carlos A. Cañas · 2020 · Journal of Thrombosis and Thrombolysis
25. Genome-Wide B Cell, CD4+, and CD8+ T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines
    Swayam Prakash, Ruchi Srivastava, Pierre-Gregoire A. Coulon, Nisha Rajeswari Dhanushkodi, Aziz Alami Chentoufi, Delia F. Tifrea, Robert A. Edwards, Cesar J. Figueroa, Sebastian Dominik Schubl, Lanny L. Hsieh et al. · 2021 · The Journal of Immunology
26. Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation
    Hanna Englert, Chandini Rangaswamy, Carsten Deppermann, Jan‐Peter Sperhake, Christoph Krisp, Danny Schreier, Emma J. Gordon, Sandra Konrath, Munif Haddad, Giordano Pula et al. · 2021 · EBioMedicine
27. Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
    Yasaman Nazerian, Mobina Ghasemi, Younes Yassaghi, Amirhossein Nazerian, Seyed Mahmoud Hashemi · 2022 · International Immunopharmacology
28. Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: identifying related therapeutic targets using network pharmacology and molecular docking analyses
    Eman M. Shawky, Ahmed A. Nada, Reham S. Ibrahim · 2020 · RSC Advances
29. Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy
    Abul Bashar Mir Md. Khademul Islam, Md. Abdullah‐Al‐Kamran Khan · 2020 · Scientific Reports
30. Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients
    Esmaeil Mortaz, Payam Tabarsi, Hamidreza Jamaati, Neda Dalil Roofchayee, Neda K. Dezfuli, Seyed Mohammad Reza Hashemian, Afshin Moniri, Majid Marjani, Majid Malekmohammad, Davood Mansouri et al. · 2021 · Frontiers in Immunology
31. Association between IL-6 and severe disease and mortality in COVID-19 disease: a systematic review and meta-analysis
    Xiaohui Liu, Hongwei Wang, Si Shi, Jinling Xiao · 2021 · Postgraduate Medical Journal
32. An Intelligent Graphene‐Based Biosensing Device for Cytokine Storm Syndrome Biomarkers Detection in Human Biofluids
    Zhuang Hao, Yang Luo, Cong Huang, Ziran Wang, Guoli Song, Yunlu Pan, Xuezeng Zhao, Shaoqin Liu · 2021 · Small
33. Development of multi-epitope peptide-based vaccines against SARS-CoV-2
    Hui Xuan Lim, Jianhua Lim, Seyed Davoud Jazayeri, Sibrandes Poppema, Chit Laa Poh · 2020 · Biomedical Journal
34. Ivermectin: an award-winning drug with expected antiviral activity against COVID-19
    Fábio Rocha Formiga, Roger Leblanc, Juliana de Souza Rebouças, Leonardo Paiva Farias, Ronaldo N. de Oliveira, Lindomar Pena · 2020 · Journal of Controlled Release
35. The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response
    Fernanda Irene Arnaldez, Steven J O'Day, Charles G. Drake, Bernard A. Fox, Bingqing Fu, Walter John Urba, Vincenzo Montesarchio, Jeffrey S. Weber, Haiming Wei, Jon M. Wigginton et al. · 2020 · Journal for ImmunoTherapy of Cancer
36. Low Albumin Levels Are Associated with Poorer Outcomes in a Case Series of COVID-19 Patients in Spain: A Retrospective Cohort Study
    Roberto de la Rica, Marcío Borges-Sa, María Aranda, Alberto del Castillo, Antònia Socías, Antoni Payeras, Gemma Rialp, Lorenzo Socías, Lluís Masmiquel, Marta González‐Freire · 2020 · Microorganisms
37. Severe Glutathione Deficiency, Oxidative Stress and Oxidant Damage in Adults Hospitalized with COVID-19: Implications for GlyNAC (Glycine and N-Acetylcysteine) Supplementation
    Premranjan Kumar, Ob W. Osahon, David B. Vides, Nicola Alexander Hanania, Charles Gene Minard, Rajagopal V. Sekhar · 2021 · Antioxidants
38. The current understanding and potential therapeutic options to combat COVID-19
    Venkatesh Pooladanda, Sowjanya Thatikonda, Chandraiah Godugu · 2020 · Life Sciences
39. COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction
    Kimberly A. Queisser, Rebecca A. Mellema, Elizabeth A. Middleton, Irina Portier, Bhanu Kanth Manne, Frederik Denorme, Ellen J. Beswick, Matthew Thomas Rondina, Robert A. Campbell, Aaron C. Petrey · 2021 · JCI Insight
40. Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy
    Xia Li, Mi Shao, Xiangjun Zeng, Pengxu Qian, He Huang · 2021 · Signal Transduction and Targeted Therapy
41. Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW
    Shichao Zheng, Jan P. A. Baak, Shuang Li, Wenke Xiao, Hong Gang Ren, Huan Yang, Yanxiong Gan, Chuanbiao Wen · 2020 · Phytomedicine
42. Excessive Matrix Metalloproteinase-1 and Hyperactivation of Endothelial Cells Occurred in COVID-19 Patients and Were Associated With the Severity of COVID-19
    Fahim Syed, Wei Li, Ryan F. Relich, Patrick M. Russell, Shanxiang Zhang, Michelle K. Zimmerman, Qigui Yu · 2021 · The Journal of Infectious Diseases
43. Neurological consequences of COVID-19: what have we learned and where do we go from here?
    Abbas Jarrahi, Meenakshi Ahluwalia, Hesam Khodadadi, Évila Lopes Salles, Ravindra B Kolhe, David Charles Hess, Fernando Ĺ. Vale, Manish Kumar, Babak Baban, Kumar Vaibhav et al. · 2020 · Journal of Neuroinflammation
44. COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management
    Zilan Wang, Yanbo Yang, Xiaolong Liang, Bixi Gao, Meirong Liu, Wen Li, Zhouqing Chen, Zhong Wang · 2020 · Frontiers in Neurology
45. Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients
    Joram Huckriede, Sara Bülow Anderberg, Albert Morales, Femke de Vries, Michael Hultström, Anders Bergqvist, José Tomás Ortiz-Pérez, Jan-Willem E. M. Sels, Kanin Wichapong, Miklós Lipcsey et al. · 2021 · Scientific Reports
46. Systemic inflammation as fuel for acute liver injury in COVID-19
    M. Effenberger, C. Grander, F. Grabherr, A. Griesmacher, T. Ploner, F. Hartig, R. Bellmann-Weiler, M. Joannidis, H. Zoller, G. Weiss et al. · 2020 · Digestive and Liver Disease
47. The impact of COVID-19 infection on the cytokine profile of pregnant women: A prospective case-control study
    Atakan Tanaçan, Nuray Yazıhan, Seyit Ahmet Erol, Ali Taner Anuk, Fatma Didem Yücel Yetişkin, Derya Biriken, Ayse Seval Ozgu-Erdinc, Hüseyin Levent Keskin, Özlem Moraloğlu Tekın, Dilek Şahın · 2021 · Cytokine
48. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study
    Man Amanat, Nima Rezaei, Mehrdad Roozbeh, Maziar Shojaei, Abbas Tafakhori, Anahita Zoghi, Ilad Alavi Darazam, Mona Salehi, Ehsan Karimialavijeh, Behnam Safarpour Lima et al. · 2021 · BMC Neurology
49. Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
    Vincent J. Venditto, Dalia Haydar, Ahmed Abdel‐Latif, John C. Gensel, Michael Anstead, Michelle G. Pitts, Jarrod W. Creameans, Timothy Joseph Kopper, Chi Peng, David J. Feola · 2021 · Frontiers in Immunology
50. Can steroids reverse the severe COVID‐19 induced “cytokine storm”?
    Lykourgos Kolilekas, Konstantinos Loverdos, Styliani Giannakaki, Lamprini Vlassi, Anastasia Levounets, Εleftherios Ζervas, Mina Gaga · 2020 · Journal of Medical Virology
51. The COVID-19 pandemic: is there a role for magnesium? Hypotheses and perspectives
    Stefano Iotti, Federica I. Wolf, Andrzej Mazur, Jeanette A.M. Maier · 2020 · Magnesium Research
52. Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion
    David Simón, Koray Taşçılar, Gerhard Krönke, Arnd Kleyer, Mario M. Zaiss, Franz Heppt, Christine Haie Meder, Raja Narayana Atreya, Entcho Klenske, Peter Dietrich et al. · 2020 · Nature Communications
53. Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
    Vincenzo Montesarchio, Roberto Parrella, Chiara Iommelli, Antonella Bianco, Elio Manzillo, Fiorentino Fraganza, Cristiana Palumbo, Gaetano Rea, Patrizia Murino, Rosanna Carmela De Rosa et al. · 2020 · Journal for ImmunoTherapy of Cancer
54. Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells
    Matthew J. Dean, Juan B. Ochoa, Maria Dulfary Sanchez‐Pino, Jovanny Zabaleta, Jone Garai, Luis Del Valle, Dorota Danuta Wyczechowska, Lyndsey Buckner Baiamonte, Phaethon Philbrook, Rinku Majumder et al. · 2021 · Frontiers in Immunology
55. COVID-19 and liver disease
    Jean‐François Dufour, Thomas Marjot, Chiara Becchetti, Herbert Tilg · 2022 · Gut
56. Understanding exosomes: Part 2—Emerging leaders in regenerative medicine
    Richard J. Miron, Nathan E. Estrin, Anton Sculean, Yufeng Zhang · 2024 · Periodontology 2000
57. Cytokine storm syndrome in severe COVID-19
    Piero Ruscitti, Onorina Berardicurti, Annamaria Iagnocco, Roberto Giacomelli · 2020 · Autoimmunity Reviews
58. Characterization of low-density granulocytes in COVID-19
    Luz E. Cabrera, Pirkka T. Pekkarinen, Maria Alander, Kirsten Nowlan, Ngoc-anh A. Nguyen, Suvi Tuulia Jokiranta, Suvi H. Kuivanen, Anu Patjas, Sointu Mero, Sari H. Pakkanen et al. · 2021 · PLoS Pathogens
59. The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic?
    Julio Villena, Haruki Kitazawa · 2020 · Frontiers in Physiology
60. Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses
    Israel Júnior Borges do Nascimento, Thilo von Groote, Dónal P O’Mathúna, Hebatullah Mohamed Abdulazeem, Catherine Henderson, Umesh Jayarajah, Ishanka Weerasekara, Tina Poklepović Peričić, Henning Klapproth, Livia Puljak et al. · 2020 · PLoS ONE
61. Montelukast in hospitalized patients diagnosed with COVID-19
    Anzalee Khan, Christian F. Misdary, Nikhil Yegya‐Raman, Sinae Kim, Navaneeth Narayanan, Sheraz Siddiqui, Padmini R. Salgame, Jared M. Radbel, Frank De Groote, Carl Michel et al. · 2021 · Journal of Asthma
62. COVID-19 and corticosteroids: a narrative review
    Gaber El‐Saber Batiha, Ali Ismail Al-Gareeb, ‏Hebatallah M. Saad, Hayder Mutter Al-Kuraishy · 2022 · Inflammopharmacology
63. Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents
    Norberto Perico, Monica Cortinovis, Fredy Suter, Giuseppe Remuzzi · 2022 · The Lancet Infectious Diseases
64. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases
    Atsunori Tsuchiya, Suguru Takeuchi, Takahiro Iwasawa, Masaru Kumagai, Takeki Sato, Satoko Motegi, Yui Ishii, Youhei Koseki, Kei Tomiyoshi, Kazuki Natsui et al. · 2020 · Inflammation and Regeneration
65. Sleep and COVID-19: considerations about immunity, pathophysiology, and treatment.
    2020 · PubMed Central
66. Overview of the pathogenesis of COVID‑19 (Review)
    Chao Li, Qifang He, Hebu Qian, Jun Liu · 2021 · Experimental and Therapeutic Medicine
67. Dietary micronutrients in the wake of COVID-19: an appraisal of evidence with a focus on high-risk groups and preventative healthcare
    Shane McAuliffe, Sumantra Ray, Emily Fallon, James Bradfield, Timothy Eden, Martin Kohlmeier · 2020 · BMJ Nutrition Prevention & Health
68. SARS‐CoV2 and pregnancy: An invisible enemy?
    Sonam Verma, Ebony Boyce Carter, Indira U. Mysorekar · 2020 · American Journal of Reproductive Immunology
69. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium
    Neal G. Ravindra, Mia Madel Alfajaro, Victor Gasque, Victoria Habet, Jin Wei, Renata B. Filler, Nicholas C. Huston, Han Wan, Klara Szigeti-Buck, Bao Wang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
70. Biosensors for Managing the COVID-19 Cytokine Storm: Challenges Ahead
    Steven M. Russell, Alejandra Alba-Patiño, Enrique Barón, Marcío Borges-Sa, Marta González‐Freire, Roberto de la Rica · 2020 · ACS Sensors
71. A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient
    Béla Nagy, Zsolt Fejes, Zoltán Szentkereszty, Renáta Sütő, István Zsolt Várkonyi, Éva Ajzner, János Kappelmayer, Zoltán Papp, Attila Tóth, Miklós Fagyas · 2020 · International Journal of Infectious Diseases
72. Virus-Induced Maternal Immune Activation as an Environmental Factor in the Etiology of Autism and Schizophrenia
    Aïcha Massrali, Dwaipayan Adhya, Deepak P. Srivastava, Simon Baron‐Cohen, Mark Kotter · 2022 · Frontiers in Neuroscience
73. The Use of Non-invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated With COVID-19: A Theoretical Hypothesis and Early Clinical Experience
    Peter S. Staats, Georgios Giannakopoulos, Justyna Blake, Eric J. Liebler, Robert M. Levy · 2020 · Neuromodulation Technology at the Neural Interface
74. The scent of COVID-19: viral (semi-)volatiles as fast diagnostic biomarkers?
    Kevin Lamote, Eline Janssens, Eline Schillebeeckx, Therese Sophie Lapperre, Benedicte Y. De Winter, Jan P. van Meerbeeck · 2020 · Journal of Breath Research
75. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System
    Larissa Braga Costa, Lucas Giandoni Perez, Vitória Andrade Palmeira, Thiago Macedo e Cordeiro, Victor Teatini Ribeiro, Katharina Lanza, Ana Cristina Simões e Silva · 2020 · Frontiers in Cell and Developmental Biology
76. Tea Bioactive Modulate Innate Immunity: In Perception to COVID-19 Pandemic
    Pritom Chowdhury, Anoop Kumar Barooah · 2020 · Frontiers in Immunology
77. COVID-19 mortality risk factors in older people in a long-term care center
    Eva Heras, Pablo Garibaldi, Maite Boix, Oliver Valero, Jorge Castillo, Yurisan Curbelo, Elso Gonzalez, Obilagilio Mendoza, Maria Anglada, Joan Carles Miralles et al. · 2020 · European Geriatric Medicine
78. Feline infectious peritonitis (FIP) and coronavirus disease 19 (COVID‐19): Are they similar?
    Saverio Paltrinieri, Alessia Giordano, Angelica Stranieri, Stefania Lauzi · 2020 · Transboundary and Emerging Diseases
79. A Systematic Review and Meta-Analysis of Hospitalised Current Smokers and COVID-19
    Jesús González-Rubio, Carmen Navarro-López, Elena López-Nájera, Ana López-Nájera, Lydia Jiménez‐Díaz, Juan D. Navarro‐López, Alberto Nájera López · 2020 · International Journal of Environmental Research and Public Health
80. A narrative review of coronavirus disease 2019 (COVID-19): clinical, epidemiological characteristics, and systemic manifestations
    Arunkumar Krishnan, James P. Hamilton, Saleh A. Alqahtani, Tinsay A. Woreta · 2021 · Internal and Emergency Medicine
81. Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19
    Yunlong Ma, Fei Qiu, Chunyu Deng, Jingjing Li, Yukuan Huang, Zeyi Wu, Yijun Zhou, Yaru Zhang, Yichun Xiong, Yinghao Yao et al. · 2022 · Genome Medicine
82. COVID-19: Pain Management in Patients with SARS-CoV-2 Infection—Molecular Mechanisms, Challenges, and Perspectives
    Sylwester Drożdżal, Jakub Rosik, Kacper Lechowicz, Filip Machaj, Bartosz Szostak, Paweł Majewski, Iwona Rotter, Katarzyna Kotfis · 2020 · Brain Sciences
83. Innate immune evasion by SARS‐CoV ‐2: Comparison with SARS‐CoV
    Abdellatif Bouayad · 2020 · Reviews in Medical Virology
84. The Sexual Long COVID (SLC): Erectile Dysfunction as a Biomarker of Systemic Complications for COVID-19 Long Haulers
    Andrea Sansone, Daniele Mollaioli, Erika Limoncin, Giacomo Ciocca, Nguyễn Hoài Bắc, Nguyễn Cao Thắng, Guangdong Hou, Jianlin Yuan, Michael Zitzmann, Annamaria G Elena Giraldi et al. · 2021 · Sexual Medicine Reviews
85. From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling
    Filippo Castiglione, Debashrito Deb, Anurag Prakash Srivastava, Píetro Lió, Arcangelo Liso · 2021 · Frontiers in Immunology
86. Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
    Tiago Ribeiro Torres, L. Puig · 2020 · American Journal of Clinical Dermatology
87. Sex Differences in Severity and Mortality Among Patients With COVID-19: Evidence from Pooled Literature Analysis and Insights from Integrated Bioinformatic Analysis
    Xiyi Wei, Yu‐Tian Xiao, Jian Wang, Rui Chen, Wei Zhang, Yue Yang, Daojun Lv, Chao Qin, Di Gu, Bo Zhang et al. · 2020 · arXiv (Cornell University)
88. Beta‐Adrenergic Blockers as a Potential Treatment for COVID‐19 Patients
    Natesan Vasanthakumar · 2020 · BioEssays
89. Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2
    Woo Ryung Kim, Eun Gyung Park, Kyung-Won Kang, Sang‐Myeong Lee, Bumseok Kim, Heui‐Soo Kim · 2020 · Molecules and Cells
90. The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression
    Wei Chieh Huang, Mei Li, Guangwei Luo, Xiaojie Wu, Bintao Su, Lan Zhao, Shuang Zhang, Xiaofan Chen, Min Jia, Jianhua Zhu et al. · 2021 · The Journal of Immunology
91. Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response
    Lucie Pearce, Sean M. Davidson, Derek M. Yellon · 2021 · Basic Research in Cardiology
92. The diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis
    Ahmed Abdelaal Ahmed Mahmoud, Mohamed Gomaa Kamel, M Hamza, Ehab Farag, Hany Mahmoud Yassin, Mohamed Elayashy, Amr Ahmed Naguib, Mohamed E. Wagih, Fatma Abd‐Elshahed Abd‐Elhay, Haytham Zien Algameel et al. · 2021 · Expert Review of Molecular Diagnostics
93. A rapid, sensitive, and reproducible in vivo PBMC humanized murine model for determining therapeutic‐related cytokine release syndrome
    Chunting Ye, Hongyuan Yang, Mingshan Cheng, Leonard D. Shultz, Dale L. Greiner, Michael A. Brehm, James Keck · 2020 · The FASEB Journal
94. Molecular optimization, docking, and dynamic simulation profiling of selective aromatic phytochemical ligands in blocking the SARS-CoV-2 S protein attachment to ACE2 receptor: an in silico approach of targeted drug designing
    Dipta Dey, Parag Kumar Paul, Salauddin Al Azad, Mohammad Faysal Al Mazid, Arman Mahmud Khan, Md. Arman Sharif, Md. Hafijur Rahman · 2021 · Journal of Advanced Veterinary and Animal Research
95. Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
    Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, Francesco Annunziato, Lorenzo Cosmi · 2021 · Seminars in Immunology
96. A perspective on yoga as a preventive strategy for coronavirus disease 2019
    Vijaya Majumdar, Raghuram Nagarathna, HR Nagendra · 2020 · International Journal of Yoga
97. A Narrative Review: The Role of NETs in Acute Respiratory Distress Syndrome/Acute Lung Injury
    Xinyu Zhou, Jiajia Jin, Tangfeng Lv, Yong Song · 2024 · International Journal of Molecular Sciences
98. Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients
    Xiang-Na Zhao, Yue You, Xiaoming Cui, Huixia Gao, Guolin Wang, Shengbo Zhang, Yao Lin, Li‐Jun Duan, Ka-Li Zhu, Yuling Wang et al. · 2021 · Signal Transduction and Targeted Therapy
99. CRISPR systems: Novel approaches for detection and combating COVID-19
    Fatemeh Safari, Mohammad Afarid, Banafsheh Rastegari, Afshin Borhani‐Haghighi, Mazyar Barekati‐Mowahed, Abbas Behzad‐Behbahani · 2021 · Virus Research
100. Plasma Linoleate Diols Are Potential Biomarkers for Severe COVID-19 Infections
     Cindy B. McReynolds, Irene Cortés‐Puch, Resmi K. Ravindran, Imran H. Khan, Bruce G. Hammock, Pei-an Betty Shih, Bruce D. Hammock, Jun Yang · 2021 · Frontiers in Physiology